Carbamazepine-induced sperm disorders can be associated with the altered expressions of testicular KCNJ11/miR-let-7a and spermatozoal CFTR/miR-27a

dc.contributor.authorTektemur, Ahmet
dc.contributor.authorEtem Onalan, Ebru
dc.contributor.authorKaya Tektemur, Nalan
dc.contributor.authorDayan Cinkara, Serap
dc.contributor.authorKilincli cetin, Ayten
dc.contributor.authorTekedereli, Ibrahim
dc.contributor.authorTurk, Gaffari
dc.date.accessioned2026-08-12T17:18:48Z
dc.date.issued2021
dc.departmentFırat Üniversitesi
dc.description.abstractMale infertility is a global health problem, and the underlying molecular mechanisms are not clearly known. Ion channels and microRNAs (miRNAs), known to function in many vital functions in cells, have been shown to play a significant role in male infertility through changes in their expressions. The study aimed to evaluate the alterations of testicular and/or spermatozoal potassium voltage-gated channel subfamily J member 11 (KCNJ11), Cystic fibrosis transmembrane conductance regulator (CFTR), miR-let-7a and miR-27a expressions in carbamazepine-related male infertility. Here, we showed that carbamazepine reduced sperm motility, increased abnormal sperm morphology, and impaired hormonal balance as well as increased relative testis weight and decreased relative seminal vesicle weight. On the other hand, downregulated KCNJ11 and upregulated miR-let-7a expressions were determined in testis (p < .05). Also, downregulated KCNJ11 and upregulated CFTR and miR-27a expressions were found in spermatozoa (p < .05). Interestingly, altered testicular KCNJ11 and miR-let-7a expressions were correlated with decreased sperm motility and elevated sperm tail defect. Besides, spermatozoal CFTR and miR-27a expressions positively correlated with sperm tail defects. The results indicated a significant relationship between ion channel and/or miRNA expression alterations and impaired sperm parameters due to carbamazepine usage.
dc.description.sponsorshipTurkiye Bilimsel ve Teknolojik Arastirma Kurumu [217S731]
dc.description.sponsorshipTurkiye Bilimsel ve Teknolojik Arastirma Kurumu, Grant/Award Number: 217S731
dc.identifier.doi10.1111/and.13954
dc.identifier.issn0303-4569
dc.identifier.issn1439-0272
dc.identifier.issue2
dc.identifier.orcid0000-0001-7417-1038
dc.identifier.orcid0000-0001-9874-3838
dc.identifier.pmid33372325
dc.identifier.scopus2-s2.0-85098136002
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1111/and.13954
dc.identifier.urihttps://hdl.handle.net/11508/53161
dc.identifier.volume53
dc.identifier.wosWOS:000603142800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofAndrologia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectcarbamazepine
dc.subjectIon channel
dc.subjectmale infertility
dc.subjectmicroRNA
dc.titleCarbamazepine-induced sperm disorders can be associated with the altered expressions of testicular KCNJ11/miR-let-7a and spermatozoal CFTR/miR-27a
dc.typeArticle

Dosyalar